Crossmark

Impact of the COVID-19 pandemic on the oncologic activities (diagnosis, treatment, clinical trials enrollment) of a general hospital in a district with high prevalence of SARS-COV-2 in Italy

Crossref DOI link: https://doi.org/10.1007/s00520-021-06667-y

Published Online: 2022-01-03

Published Print: 2022-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ambroggi, Massimo

Citterio, Chiara

Vecchia, Stefano

Riva, Alessandra

Mordenti, Patrizia

Cavanna, Luigi http://orcid.org/0000-0002-0303-3778
License Information

Text and Data Mining valid from 2022-01-03

Version of Record valid from 2022-01-03
More Information

Article History

Received: 17 June 2021

Accepted: 1 November 2021

First Online: 3 January 2022

Declarations

:

: This study was approved by the local ethics committee (Institutional Review Board approval number 493/2020/OSS*/AUSLPC), ASL of Piacenza.

: Not applicable.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below